WuXi Biologics (Cayman) Inc.

HK$47.62As of Sun 8 Nov 2026, 12:00 UTC
HKEX:2269Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 9Y CAGR 18.70%
Div yield —
ROE 11.38%
Biotechnology
Beta (5Y) 0.59
PE TTM 34.82
TSR TTM 34.48%
Mkt cap HK$195.4B
ROIC 13.88%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$58
21.76%
(58.15%)
Hold 1|5|4|12|4
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.46
0.44
0.48
0.49
12.09%
9.81%
23.49%
13.68%
Revenue¥B
13.15
13.61
13.75
14.45
3.30%
4.25%
4.81%
11.80%
Peers (US$24.93B)
Cap (US$)
PE
19.18B
107.5x
10.23B
—
Capital
TTM
5Y
10Y
Leveragex
0.732
(0.078)
(0.081)
EBIT/Intx
0.116
0.091
0.102
Own earn%
(12.01)
68.00
61.43
Sh yield%
21.85
47.38
48.64
Owners
Insiders/Inst%
1.94
76.48
Short interest%
0.99
SBC / revenue%
2.61
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
3–10
$1 testx
—
Incr. ROIC%
6